Regarding the joint announcement by the three departments on including 46 substances including brorophine in the 'Supplementary Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances'

Dear Supplier:

In order to prevent the spread of abuse of new psychoactive substances and crack down on related criminal activities, the Ministry of Public Security, the National Health Commission, and the National Medical Products Administration jointly issued the "Announcement on Including 46 Substances including Brorophine in the 'Supplementary Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances'" on June 16, 2024, deciding to newly manage 46 new psychoactive substances including brorophine, which will be implemented from July 1, 2024. For details, please click to view:

三部门联合发布《关于将溴啡等46种物质列入〈非药用类麻醉药品和精神药品管制品种增补目录〉的公告》-中国禁毒网 (nncc626.com)

We hope that all users of the ECHEMI platform can comply with relevant national laws and regulations when engaging in business activities, and use the platform in a reasonable and standardized manner. If the provisions of the "ECHEMI Platform Prohibited and Restricted Sales Catalogue Rules" (Announcement on the list of prohibited sales of Prohibited and Controlled Items on ECHEMI) are violated, the products in violation will be removed from the platform, and the platform will punish the users accordingly. 

www.echemi.com

June 24, 2024